Skip to Content

Tag: diabetes


Russ Johannesson

Specialty Providers

Glooko raises stakes on remote monitoring 

April 2, 2021Theresa Flaherty, Managing Editor

PALO ALTO, Calif. – Glooko saw its remote monitoring business take off in 2020 and plans to use recent funding to increase adoption of its platform by diabetes patients and their health care providers.  The company, which provides a software-as-a-service application and accompanying mobile app, will ramp up its marketing, among other efforts, after raising $30 million in Series D funding.  “Remote monitoring is a solution we’ve...

diabetes, Glooko, remote patient monitoring, Russ Johannesson


Read Full Articlered right arrow icon

Specialty Providers

Glooko raises $30M to accelerate growth

March 17, 2021HME News Staff

PALO ALTO, Calif. – Glooko, a provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, has raised a $30 million Series D round of funding.   The company will use proceeds from the funding to accelerate organic growth and strategic initiatives across its product line of digital health solutions, including increasing adoption of is remote patient monitoring platform, widening commercialization of products...

diabetes, Glooko, remote monitoring


Read Full Articlered right arrow icon

Also Noted

Insulet posts Q4 revenue increase, net loss

February 24, 2021HME News Staff

ACTON, Mass. – Insulet  reported revenues of $246.1 million for the fourth quarter of 2020, an increase of 17.5% over the same quarter in 2019. Full-year revenues were $904.4 million, an increase of 22.5% compared to the previous year. For the quarter, U.S. Omnipod revenue was $231.1 million and International Omnipod revenue was $149.2 million. Omnipod revenue for the full year was $834.9 million: $526.9 million in U.S. Omnipod...

diabetes, insulet, OmniPod


Read Full Articlered right arrow icon

Vendors

Dexcom enters VC space

February 15, 2021HME News Staff

SAN DIEGO – Dexcom has launched Dexcom Ventures to identify and invest in opportunities to supplement growth in its core business of continuous glucose monitoring and advance the development of adjacent technologies.  Dexcom Ventures, led by Dexcom veteran Steve Pacelli, will be focused on investment opportunities in sensing technology, data analytics, remote patient monitoring and population health, broadening the company’s commitment to advancing better outcomes in health care.  “Driven...

continuous glucose monitoring, dexcom, diabetes, venture capital


Read Full Articlered right arrow icon

Also Noted

Ascensia supports Spare a Rose campaign

February 11, 2021HME News Staff

BASEL, Switzerland – Ascensia Diabetes Care is supporting the 2021 Spare a Rose campaign, which encourages people to donate the $5 cost of each rose they would have given someone on Valentine’s Day to Life for a Child. The organization provides lifesaving diabetes supplies and insulin to children in countries such as Mauritania, Jamaica and India. “While people around the world will be buying flowers and cards for their loved on this Valentine’s Day, many of...

Ascensia, diabetes, insulin, Spare a Rose Campaign


Read Full Articlered right arrow icon

Also Noted

DarioHealth appoints digital health expert 

January 21, 2021HME News Staff

NEW YORK – DarioHealth has named Chris Chan senior vice president of employer sales, responsible for leading growth initiatives in the self-insured employer market. Chan previously worked as chief marketing officer at SleepQuest, a sleep apnea-focused technology and telehealth company, and he also founded the Mercer LABS and the Health Imagination Innovation Team at Willis Towers Watson. He has an extensive background in digital health, care delivery...

Chris Chan, DarioHealth, diabetes, digital health


Read Full Articlered right arrow icon

Specialty Providers

Medtronic aims to ‘bridge’ coverage gaps 

December 18, 2020Theresa Flaherty, Managing Editor

DUBLIN – The biggest barrier to CGMs and other innovative diabetes technology is cost, says Medtronic, and that’s why the company recently launched a CGM Access Discount Program for certain users.  “Our goal is to make therapy available to everyone and we hear cost is one of the top reasons they can’t go on CGMs or fall off (using CGMs),” says Krista Sugerman, vice president of global customer engagement for Medtronic. “We try to...

CGMs, CMS, diabetes, Medtronic


Read Full Articlered right arrow icon

Pinnacle Medical Solutions gets ‘bigger seat at table’ 

Specialty Providers

Pinnacle Medical Solutions gets ‘bigger seat at table’ 

December 18, 2020Theresa Flaherty, Managing Editor

CHICAGO - With the diabetes management industry growing by leaps and bounds, Frank Brumfield, CEO and owner of FSB Companies, a private investment firm, knew it was time to sell Pinnacle Medical Solutions, a company he’s been involved with since 2006.  “We’re excited to plug in the patient-focus model that The FSB Companies and the Pinnacle management team had built over the years into a much broader platform,” he said. “We wanted to be able to continue...

AdaptHealth, CGMs, diabetes, Frank Brumfield, Pinnacle Medical Solutions


Read Full Articlered right arrow icon

Also Noted

Medtronic launches discount program

December 3, 2020HME News Staff

DUBLIN - Medtronic has launched a CGM Access Discount program that allows users without insurance coverage or those who switched insurance or lost coverage to access discounted out-of-pocket costs for a Medtronic CGM. The discount enables eligible patients to pay $180 for a Medtronic CGM (with a 12-month warranty) and $60/month for sensors. For more information on the program, click here. In October, CMS announced proposed changes that, if finalized, would expand Medicare coverage for CGMs. Earlier...

CGMs, diabetes, Medtronic


Read Full Articlered right arrow icon

Also Noted

DarioHealth sees 3Q revenues increase

November 12, 2020HME News Staff

NEW YORK - DarioHealth reported revenues of $2.04 million for the quarter ended Sept. 30, 2020, an increase of 14.2% from the second quarter ended June 30, 2020. Gross profit was $549,000, a decrease of $324,000 or 37% from the previous quarter in 2019. The company said the decrease is a result of a decrease in the average selling price of its products. Total operating expenses for the quarter were $7.15 million, operating loss was $6.6 million, and net loss was $6.55 million. Highlights from the...

DarioHealth, diabetes


Read Full Articlered right arrow icon